Cipla | eHealth Magazine

In a bid to acquire the minority stake in the Mumbai-based firm for a cash consideration of Rs 10.5 crore, […]

An agreement has been signed to fully acquire South Africa’s Mirren (Pty) Ltd by drug major Cipla’s subsidiary for a […]

Drug firm Cipla now gets right to market and sale inhaled insulin, Afrezza in India after making an exclusive agreement […]

Cipla Ltd has appointed Peter Lankau as an independent director on its board with effect from 10th January 2017. Lankau […]

Ireena Vittal, a former partner with McKinsey & Co and senior management consultant with over two decades of experience, has […]

Cipla, the Indian pharmaceutical has inked an agreement with Dube Trade Port Special Economic Zone, a business entity of KwaZulu-Natal, […]

Major Indian drug makers Cipla and Wockhardt are among a group of 13 global pharmaceutical firms which have come together […]

Cipla, a leading drug maker signed an investment agreement with FIL Capital Investments (Mauritius) II Limited for its consumer healthcare […]

Cipla has entered into an agreement to sell its entire 25 per cent stake in Biomad Holding Limited, Hong Kong […]

Emerging markets are predicted to account for a third of global pharmaceutical spend by the end of next year and […]

The Dadha Group owned NetMeds.com, an e-marketplace for pharma to offer delivery across the country announced the commencement of its […]

Cipla has launched a generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name ‘Hepcvir’ in India. The […]

Cipla (EU) Ltd., a wholly-owned subsidiary of Mumbai based drug firm Cipla Ltd., has inked the joint venture agreement with […]

document.write(currentDate);